3 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow Santen SAS: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease Latanoprost, Travatan Z - Glaucoma, Ocular Hypertension | Phase 2 | Completed | Santen SAS | 105 | 2010-11-01 | 2016-06-06 |
| NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye NOVA22007 ''Cyclosporine'', vehicle/placebo - Dry Eye | Phase 2 | Completed | Santen SAS | 132 | 2008-08-01 | 2016-06-06 |
| Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC) Cyclosporine NOVA22007 0.05%, Cyclosporine NOVA22007 0.1%, Vehicle - Conjunctivitis, Vernal | Phase 2 / Phase 3 | Completed | Santen SAS | 118 | 2006-05-01 | 2021-12-14 |
Conjunctivitis, Allergic (1) · Dry Eye Syndromes (1) · Glaucoma (1) · Hypersensitivity (1) · Ocular Hypertension (1)
Latanoprost (1) · Travoprost (1)
United States (2) · France (1)
Christophe Baudouin, Pf. (1) · David BenEzra, Pf (1)